HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 9.98

Change

+0.04 (+0.40)%

Market Cap

CAD 0.08B

Volume

2.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.06 (+0.15%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

-0.20 (-0.27%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.35 (+0.61%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.18 (+0.82%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.10 (+0.54%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.10 (-0.44%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.59 (-0.99%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.11 (-0.38%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.21 (-0.33%)

CAD 0.28B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.43% 31% F 39% F
Dividend Return 2.90% 69% C- 62% D
Total Return 10.32% 43% F 44% F
Trailing 12 Months  
Capital Gain 9.55% 23% F 31% F
Dividend Return 2.95% 68% D+ 49% F
Total Return 12.50% 20% F 33% F
Trailing 5 Years  
Capital Gain -58.66% 6% D- 8% B-
Dividend Return 7.89% 59% D- 29% F
Total Return -50.77% 6% D- 9% A-
Average Annual (5 Year Horizon)  
Capital Gain -2.47% N/A N/A 22% F
Dividend Return -0.16% N/A N/A 25% F
Total Return 2.31% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 40.77% N/A N/A 22% F
Risk Adjusted Return -0.39% N/A N/A 26% F
Market Capitalization 0.08B 47% F 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.